Great bifurcation decision case @CRT_meeting by the great @mirvatalasnag an panel @HadyLichaaMD@lindsey_cilia@Kandzari
1️⃣How many of you are using DCBs to treat the size branch?
2️⃣How often do you reach for IVL specifically because of concern of side branch loss with atherectomy?
#CRT2026 #HighRiskPCI
🚀 A major milestone for the CT-guided PCI 🚀
We are thrilled with the enrollment of the first patient in the "P5" OPTIMAL randomized clinical trial 💪
This is the second large RCT evaluating the value of CT-guided PCI. This time, in patients with severe coronary calcification
👏 Congratulations to Dr. @foroic and the team at Hospital de León 🇪🇸 for successfully enrolling the first patient in Spain!
We now look forward to the start of recruitment across:🇧🇪 |🇩🇰 | 🇬🇧 | 🇺🇸
@TCTMD@crfheart@fundacionepic@jcspratt@esbrilakis@yadersandoval@BartsIntervGrp@PCRonline@Heartflow@ShockwaveIVL
Additional randomized IVL data presented at #TCT2025 show the continued benefits of #ShockwaveIVL in severely calcified lesions.
US Rx only. ISI https://t.co/sZ0NdzXNcV
NEW DATA: A recently published cadaveric study demonstrated #ShockwaveIVL’s ability to produce more calcium fracture and cause less medial injury than cutting balloons and ultra high-pressure balloons. Read our latest blog for more, including a roundtable discussion with the study’s principal investigators Drs. @ziadalinyc and @AlokeFinn: https://t.co/AUeEBw1baq
US Rx only. ISI https://t.co/x46wohjBQF
Nothing like the live case banter from Simon Wilson and Rob Riley to entertain while learning a lot about CT-guided PCI during the live case with RotaShock calcium modification at #OptimaPCI@OptimaCTO
Coming out of the session "New evidence for treatment of calcified CAD" at #EuroPCR, where @JuradoRomanAl just presented the results of The ROLLER COASTR-EPIC22 Trial @mirvatalasnag asked him to share the key findings of this study that focuses on contemporary tool used for calcium modification 🎤
Impressive #EuroPCR live case from @JEscaned & @NievesGonzalo1 on the use of CT to plan and manage cases - the dynamic Madrid duo positioned the IVL catheter based on the co-reg CT overlay image on the left before delivering/managing pulses. Definitely watching the future here...
LATE BREAKER: Dr @mbmcentegart presented the #EMPOWERCAD 30-day outcomes at #EuroPCR. Unlike other calcium modification therapies, #ShockwaveIVL has shown consistently low angiographic complications in both female and male patients. EMPOWER CAD evaluated a real-world, all-comer, high-risk female patient population utilizing an IVL- first strategy.
See the 30-day primary endpoints in this first of its kind study: https://t.co/YVigqRNDtC
US Rx only. ISI https://t.co/x46wohjBQF @PCRonline
1)🚨 New study from the BENELUX-IVL registry: "Intravascular lithotripsy and temporary mechanical circulatory support for the treatment of heavily calcified coronary artery disease"
https://t.co/ULzMUCAIE5
Key findings👇
Great session at #SCAI2025 yesterday highlighting the potential increasing role for CCTA in PCI planning and simultaneously expert opinion statement from SCAI/SCCT published in @MyJSCAI https://t.co/PtpnxPmcoL
Congratulations to Dr Evan Shlofmitz (@ESHLOF), Dr Ziad Ali (@ziadalinyc) & the team at St. Francis Hospital & The Heart Center (@StFrancis_LI) in Roslyn, New York on pioneering the next era of IVL by treating the first patients with the novel #ShockwaveJavelin Coronary IVL catheter in its pivotal study, #FORWARDCAD.
Read more in the Press Release: https://t.co/oYN4wL2HCD
CAUTION – Investigational device. Limited by Federal (or United States) law to investigational use.
Good discussion in the post-ECLIPSE era about the thresholds for advanced calcium modification strategies at #CTO2025 between Jeff Moses and @ziadalinyc and moderated by Ajay Kirtane -poll results are pre- and post-discussion...not much movement
@jedicath@yadersandoval Indeed - a lot of work to be done in this respect but stay tuned for SCAI & SCCT initiatives focused on increasing CCTA access for ICs
A potential paradigm shift on the horizon? Great presentation by @yadersandoval at #CTOPlus about the benefits of CCTA for pre-PCI procedural planning -- especially in calcified lesions
#EuroPCR is just around the corner, and we’re excited for the Late-Breaking Trials! On May 16th don’t miss the session, “First results of randomised trials on advanced plaque modification techniques and intracoronary imaging” as Drs @nicolasamabile, @Bernard_TW_Wong and @AJuradoRoman will provide updates from three of the most important ongoing studies including #ShockwaveIVL.
US Rx only. ISI https://t.co/x46wohjBQF @PCRonline